These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12527582)

  • 1. Chemotherapeutic management of stage IV non-small cell lung cancer.
    Socinski MA; Morris DE; Masters GA; Lilenbaum R;
    Chest; 2003 Jan; 123(1 Suppl):226S-243S. PubMed ID: 12527582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal duration of chemotherapy in advanced non-small cell lung cancer.
    Lustberg MB; Edelman MJ
    Curr Treat Options Oncol; 2007 Feb; 8(1):38-46. PubMed ID: 17634834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition).
    Socinski MA; Crowell R; Hensing TE; Langer CJ; Lilenbaum R; Sandler AB; Morris D;
    Chest; 2007 Sep; 132(3 Suppl):277S-289S. PubMed ID: 17873174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and prognostic factors of 178 advanced non-small lung cancer patients undergoing different second-line chemotherapeutic regimens].
    Kong Q; Wang XY; Jiang RC; Ba Y; Li K
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):294-9. PubMed ID: 27087377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Treatment Patterns With Advanced or Recurrent Non-small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database Study.
    Wang F; Mishina S; Takai S; Le TK; Ochi K; Funato K; Matsuoka S; Ohe Y
    Clin Ther; 2017 Jun; 39(6):1146-1160. PubMed ID: 28527959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Hockenhull J; Proudlove C; Dundar Y; Richardson M; Dickson R; Mullard A; Marshall E
    Health Technol Assess; 2015 Jun; 19(47):1-134. PubMed ID: 26134145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chemotherapy in the treatment of unresectable stage III and IV nonsmall cell lung cancer.
    Socinski MA
    Respir Care Clin N Am; 2003 Jun; 9(2):207-36. PubMed ID: 12911290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines.
    Wang J; Li G; Yu L; Mo T; Wu Q; Zhou Z
    J Ethnopharmacol; 2018 Jul; 221():137-150. PubMed ID: 29655852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer.
    Berthelot JM; Will BP; Evans WK; Coyle D; Earle CC; Bordeleau L
    J Natl Cancer Inst; 2000 Aug; 92(16):1321-9. PubMed ID: 10944554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
    Ciuleanu T; Stelmakh L; Cicenas S; Miliauskas S; Grigorescu AC; Hillenbach C; Johannsdottir HK; Klughammer B; Gonzalez EE
    Lancet Oncol; 2012 Mar; 13(3):300-8. PubMed ID: 22277837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in stage IV (metastatic) non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Lopez PG; Stewart DJ; Newman TE; Evans WK
    Cancer Prev Control; 1997; 1(1):18-27. PubMed ID: 9765723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatments for advanced stage non-small cell lung cancer.
    Stinchcombe TE; Socinski MA
    Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy.
    Grossi F; Genova C; Rijavec E; Barletta G; Biello F; Dal Bello MG; Meyer K; Roder J; Roder H; Grigorieva J
    Lung Cancer; 2018 Mar; 117():64-69. PubMed ID: 29395121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-effectiveness analysis of docetaxel versus pemetrexed in second-line chemotherapy for stage IIIb or IV non-small cell lung cancer in China.
    Yu YF; Chen ZW; Zhou Z; Song ZB; Li ZM; Jian H; Zhang YF; Lu S
    Chemotherapy; 2010; 56(6):472-7. PubMed ID: 21099219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.
    Shukuya T; Ko R; Mori K; Kato M; Yagishita S; Kanemaru R; Honma Y; Shibayama R; Koyama R; Shimada N; Takahashi K
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):771-6. PubMed ID: 26259641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-small-cell lung cancer progression after first-line chemotherapy.
    Lara PN; Lau DH; Gandara DR
    Curr Treat Options Oncol; 2002 Feb; 3(1):53-8. PubMed ID: 12057087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stage IV non small cell bronchial carcinoma; first line therapy in 2007].
    Lemarié E
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S101-7. PubMed ID: 18235401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.